Investing.com - AbbVie (NYSE:ABBV) reported on Friday fourth quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
AbbVie announced earnings per share of $2.21 on revenue of $8.70B. Analysts polled by Investing.com anticipated EPS of $2.19 on revenue of $8.7B. That with comparison to EPS of $1.9 on revenue of $8.31B in the same period a year before.AbbVie had reported EPS of $2.33 on revenue of $8.48B in the previous quarter.Analysts are expecting EPS of $2.11 and revenue of $8.02B in the upcoming quarter.
AbbVie shares are down 1% from the beginning of the year and are trading at $88.80 , down-from-52-week-high.They are under-performing the S&P 500 which is up 3.12% year to date.
AbbVie shares gained 1.86% in pre-market trade after the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie's report follows an earnings beat by J&J on Wednesday, January 22, 2020, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday, January 29, 2020 with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar